Edgewise Therapeutics (EWTX) News Today → World’s biggest multibillionaire investor is buying THIS by the ton [picture] (From Stansberry Research) (Ad) Free EWTX Stock Alerts $15.49 -0.62 (-3.85%) (As of 02:58 PM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineEdgewise Receives European Medicines Agency (EMA) Orphan Drug Designations for Sevasemten (EDG-5506) for the Treatment of Becker and Duchenne Muscular Dystrophiesbusinesswire.com - April 23 at 8:00 AMEdgewise Therapeutics (NASDAQ:EWTX) Price Target Increased to $32.00 by Analysts at Royal Bank of Canadaamericanbankingnews.com - April 23 at 3:50 AMEdgewise Therapeutics (NASDAQ:EWTX) Shares Gap Up Following Analyst Upgradeamericanbankingnews.com - April 23 at 1:06 AMEdgewise Therapeutics (NASDAQ:EWTX) Shares Gap Up After Analyst Upgrademarketbeat.com - April 22 at 12:49 PMRoyal Bank of Canada Boosts Edgewise Therapeutics (NASDAQ:EWTX) Price Target to $32.00marketbeat.com - April 22 at 12:12 PMJANX Janux Therapeutics, Inc.seekingalpha.com - April 22 at 11:14 AMEdgewise Therapeutics (NASDAQ:EWTX) Stock Rating Reaffirmed by Truist Financialamericanbankingnews.com - April 19 at 1:58 AMVontobel Holding Ltd. Makes New Investment in Edgewise Therapeutics, Inc. (NASDAQ:EWTX)marketbeat.com - April 18 at 6:14 AMEdgewise reports positive Becker trial results, plans discussioninvesting.com - April 17 at 3:50 PMAnalysts Offer Insights on Healthcare Companies: Edgewise Therapeutics (EWTX) and Progyny (PGNY)markets.businessinsider.com - April 17 at 3:50 PMEdgewise Therapeutics (NASDAQ:EWTX) Given Buy Rating at Truist Financialmarketbeat.com - April 17 at 3:45 PMEdgewise Therapeutics (NASDAQ:EWTX) Stock Price Down 3.4%marketbeat.com - April 17 at 12:20 PMEdgewise Therapeutics (NASDAQ:EWTX) Given "Outperform" Rating at Wedbushamericanbankingnews.com - April 17 at 4:44 AMEdgewise Therapeutics' (EWTX) Outperform Rating Reaffirmed at Wedbushmarketbeat.com - April 16 at 11:00 AMEdgewise Therapeutics Announces Positive Two-Year Topline Results from the ARCH Open Label Trial of Sevasemten (EDG-5506) in Adults with Becker Muscular Dystrophy (Becker)businesswire.com - April 15 at 4:05 PMShort Interest in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Expands By 27.7%marketbeat.com - April 15 at 2:48 PMEdgewise Therapeutics (NASDAQ:EWTX) Trading Up 4.2%marketbeat.com - April 5 at 12:51 PMEdgewise Therapeutics (NASDAQ:EWTX) Trading Down 5.6%marketbeat.com - April 4 at 5:28 PMShort Interest in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Decreases By 17.9%marketbeat.com - March 30 at 8:18 PMEdgewise Therapeutics Announces Upcoming Podium Presentation at the American College of Cardiology's 2024 Annual Scientific Sessionbusinesswire.com - March 28 at 8:00 AMEdgewise Therapeutics to Present at the Cantor Virtual Muscular Dystrophy Symposium on April 2, 2024businesswire.com - March 27 at 8:00 AMEdgewise Therapeutics, Inc. (NASDAQ:EWTX) Sees Significant Increase in Short Interestmarketbeat.com - March 18 at 9:35 PMEdgewise Therapeutics (NASDAQ:EWTX) Stock Price Down 5.8%marketbeat.com - March 18 at 12:44 PMEdgewise Therapeutics (NASDAQ:EWTX) Stock Price Up 5.2%marketbeat.com - March 15 at 12:59 PMEdgewise Therapeutics (NASDAQ:EWTX) Coverage Initiated by Analysts at Piper Sandlermarketbeat.com - March 7 at 8:21 AMEdgewise Therapeutics to Present at the Leerink Partners Global Biopharma Conference on March 11, 2024finance.yahoo.com - March 5 at 9:30 AMFmr LLC Lowers Stock Holdings in Edgewise Therapeutics, Inc. (NASDAQ:EWTX)marketbeat.com - March 3 at 5:14 AMEdgewise Therapeutics to Present on EDG-5506 for the Treatment of Becker Muscular Dystrophy at the 2024 MDA Clinical and Scientific Conferencebusinesswire.com - February 28 at 8:00 AMWall Street Analysts Predict a 52.78% Upside in Edgewise Therapeutics, Inc. (EWTX): Here's What You Should Knowfinance.yahoo.com - February 26 at 3:37 PMEdgewise Therapeutics earnings missed by $0.04, revenue was in line with estimatesinvesting.com - February 25 at 12:52 AMEdgewise Therapeutics (EWTX) Price Target Increased by 8.00% to 27.54msn.com - February 24 at 9:49 AMEdgewise Therapeutics Stock (NASDAQ:EWTX), Short Interest Reportbenzinga.com - February 22 at 9:29 PMEdgewise Therapeutics: Q4 Earnings Insightsbenzinga.com - February 22 at 2:57 PMEdgewise Therapeutics Non-GAAP EPS of $0.47msn.com - February 22 at 2:57 PMEdgewise Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highlightsfinance.yahoo.com - February 22 at 9:56 AMEdgewise Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highlightsbusinesswire.com - February 22 at 8:00 AMEdgewise Therapeutics Inc (EWTX)investing.com - February 22 at 4:55 AMAnalysts Are Bullish on These Healthcare Stocks: Edgewise Therapeutics (EWTX), Bicycle Therapeutics (BCYC)markets.businessinsider.com - February 22 at 4:55 AMNew York State Common Retirement Fund Acquires 30,522 Shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX)marketbeat.com - February 22 at 4:14 AMEdgewise Therapeutics (NASDAQ:EWTX) Trading Up 3.6%marketbeat.com - February 20 at 11:56 AMEWTX May 2024 30.000 callfinance.yahoo.com - February 16 at 11:00 PMEdgewise Receives U.S. FDA Fast Track Designation for EDG-5506 for the Treatment of Duchenne Muscular Dystrophy (Duchenne)finance.yahoo.com - February 13 at 8:34 AMEdgewise Therapeutics, Inc. (NASDAQ:EWTX) Insider Sells $92,046.00 in Stockmarketbeat.com - February 9 at 7:06 PMWall Street Analysts See a 33.27% Upside in Edgewise Therapeutics, Inc. (EWTX): Can the Stock Really Move This High?finance.yahoo.com - February 9 at 12:55 PMEdgewise Therapeutics (NASDAQ:EWTX) Sets New 12-Month High at $19.83marketbeat.com - February 7 at 10:49 AMEdgewise Therapeutics (NASDAQ:EWTX) Sets New 12-Month High at $18.35marketbeat.com - February 1 at 10:44 AMHow Is The Market Feeling About Edgewise Therapeutics?benzinga.com - January 31 at 6:35 PMEdgewise Therapeutics Inc CFO R Carruthers Sells 90,000 Sharesfinance.yahoo.com - January 26 at 2:29 AMWall Street Analysts Think Edgewise Therapeutics, Inc. (EWTX) Could Surge 70.76%: Read This Before Placing a Betfinance.yahoo.com - January 24 at 5:29 PMEdgewise Therapeutics, Inc. (NASDAQ:EWTX) Forecasted to Earn FY2023 Earnings of ($1.50) Per Sharemarketbeat.com - January 24 at 6:26 AM Get Edgewise Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for EWTX and its competitors with MarketBeat's FREE daily newsletter. Email Address World’s biggest multibillionaire investor is buying THIS by the ton [picture] (Ad)Don't Buy Bullion or Mining Stocks. Do THIS Instead As gold continues to break all-time highs, many folks will run out and buy bullion or mining stocks. That's not the best way to ride this gold bull market higher. Note, this showed a 995% gain the last time we shared this same investment idea. Click here to find out what to do. EWTX Media Mentions By Week EWTX Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. EWTX News Sentiment▼0.690.42▲Average Medical News Sentiment EWTX News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. EWTX Articles This Week▼81▲EWTX Articles Average Week Get Edgewise Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for EWTX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Ardelyx News Today Protagonist Therapeutics News Today Taro Pharmaceutical Industries News Today Dynavax Technologies News Today Supernus Pharmaceuticals News Today Agios Pharmaceuticals News Today Avadel Pharmaceuticals News Today Arcus Biosciences News Today Zai Lab News Today Amneal Pharmaceuticals News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:EWTX) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarThe A.I. story nobody is telling you (Read ASAP)TradeSmithRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldHe Is Giving Away BitcoinCrypto Swap Profitstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyYour Money is Not SafeAmerican Alternative Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Edgewise Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
